DIFLORASONE Drug Patent Profile

Which patents cover Diflorasone, and what generic alternatives are available?

Diflorasone is a drug marketed by Ani Pharms, Avondale Pharms, Sun Pharma Canada, Rising, Sciegen Pharms, and The J Molner. and is included in eight NDAs.

The generic ingredient in DIFLORASONE is diflorasone diacetate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the diflorasone diacetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Diflorasone

A generic version of DIFLORASONE was approved as diflorasone diacetate by AVONDALE PHARMS on April 27^th, 1999.

Summary for DIFLORASONE

US Patents:	0
Applicants:	6
NDAs:	8
Drug Prices:	Drug price information for DIFLORASONE
DailyMed Link:	DIFLORASONE at DailyMed

See drug prices for DIFLORASONE

US Patents and Regulatory Information for DIFLORASONE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	CREAM;TOPICAL	076263-001	Dec 20, 2002		DISCN	No	No
Sun Pharma Canada	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	075331-001	May 14, 1999	AB	RX	No	Yes
Avondale Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	075374-001	Apr 27, 1999	AB	RX	No	No
The J Molner	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	210753-001	Jun 12, 2018	AB	RX	No	No
Avondale Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	CREAM;TOPICAL	075187-001	Mar 30, 1998		DISCN	No	No
Sun Pharma Canada	DIFLORASONE DIACETATE	diflorasone diacetate	CREAM;TOPICAL	075508-001	Apr 24, 2000	BX	RX	No	Yes